Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8201
PUT
New York Times
NYT
$10.5B
| $505K | ﹤0.01% |
13,000
-14,200
| -52% | -$523K |
|
8202
1st Source
SRCE
$2.12B
| $505K | ﹤0.01% |
11,710
+5,232
| +81% | +$256K |
|
8203
CALL
Werner Enterprises
WERN
$2.35B
| $505K | ﹤0.01% |
11,100
+9,300
| +517% | +$422K |
|
8204
Praxis Precision Medicines
PRAX
$10.3B
| $505K | ﹤0.01% |
41,586
-8,769
| -17% | -$370K |
|
8205
OmniAb Inc Warrant
OABIW
$27.8M
| $504K | ﹤0.01% |
913,334
-48,020
| -5% | -$28.8K |
|
|
KNDI
8206
Kandi Technologies Group
KNDI
$63.3M
| $504K | ﹤0.01% |
182,688
-64,009
| -26% | -$162K |
|
|
SP
8207
CALL
DELISTED
SP Plus Corporation
SP
| $504K | ﹤0.01% |
14,700
-4,600
| -24% | -$163K |
|
|
LSXMA
8208
PUT
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $503K | ﹤0.01% |
24,362
+15,788
| +184% | +$396K |
|
8209
PUT
Arvinas
ARVN
$602M
| $503K | ﹤0.01% |
18,400
-77,300
| -81% | -$2.44M |
|
8210
PUT
Privia Health
PRVA
$2.75B
| $503K | ﹤0.01% |
18,200
+10,100
| +125% | +$267K |
|
|
RUTH
8211
CALL
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $502K | ﹤0.01% |
30,600
-62,300
| -67% | -$1.08M |
|
8212
PUT
Deluxe
DLX
$1.11B
| $502K | ﹤0.01% |
31,400
-14,100
| -31% | -$257K |
|
8213
PUT
Twist Bioscience
TWST
$7.28B
| $502K | ﹤0.01% |
33,300
+20,800
| +166% | +$459K |
|
8214
PUT
Zevra Therapeutics
ZVRA
$685M
| $502K | ﹤0.01% |
91,300
+15,400
| +20% | +$81.5K |
|
8215
PUT
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
| $502K | ﹤0.01% |
11,000
+6,000
| +120% | +$273K |
|
8216
Harrow
HROW
$1.48B
| $502K | ﹤0.01% |
23,711
-33,516
| -59% | -$572K |
|
8217
Nurix Therapeutics
NRIX
$2.79B
| $502K | ﹤0.01% |
56,490
-62,717
| -53% | -$654K |
|
8218
FT Vest US Equity Deep Buffer ETF August
DAUG
$374M
| $501K | ﹤0.01% |
+15,596
| New | +$494K |
|
8219
CALL
Arbutus Biopharma
ABUS
$932M
| $501K | ﹤0.01% |
165,300
-67,700
| -29% | -$191K |
|
8220
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.21B
| $501K | ﹤0.01% |
8,038
+1,178
| +17% | +$73.2K |
|
8221
CALL
Compass Minerals
CMP
$1.08B
| $501K | ﹤0.01% |
14,600
-39,100
| -73% | -$1.56M |
|
8222
PUT
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
$41.5B
| $500K | ﹤0.01% |
11,100
-4,200
| -27% | -$180K |
|
8223
BayCom
BCML
$334M
| $500K | ﹤0.01% |
29,274
-8,387
| -22% | -$161K |
|
8224
PUT
Primerica
PRI
$9.54B
| $499K | ﹤0.01% |
2,900
+1,700
| +142% | +$279K |
|
8225
CALL
Tradr 1.25X NVDA Bear Daily ETF
NVDS
$13.4M
| $499K | ﹤0.01% |
+415
| New | +$749K |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.